Investors expect the company to underperform the broader ind...
Investors expect the company to underperform the broader industry, reflecting in its low P/S ratio. Limited growth rates are anticipated to persist, reducing stock value. If medium-term revenue trends persist, a share price reversal seems unlikely.
COFCO Biotechnology Co., Ltd. (SZSE:000930) Looks Inexpensive But Perhaps Not Attractive Enough
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment